Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
15 lessons
9mUBT251 is a once-weekly GLP-1, GIP and glucagon receptor agonist in development in China. Two phase 2 trials published in Cell Metabolism in October 2026. Here is what they measured, how to read the numbers, and why they can't be ranked against retatrutide.
9mSLU-PP-332 is a synthetic small molecule that activates estrogen-related receptors linked to exercise biology. Here is what the mouse studies actually show, and what is still unknown in humans.
10mSS-31 and MOTS-c sit at the intersection of mitochondria and metabolism hype. Separate published human research from forum dosing before you track either compound.
8mGLP-1 drugs do more than blunt hunger. They change the signals that shape appetite, food reward, and energy balance, which is why the mechanism matters.
9mMOTS-c looks interesting because it can push metabolism in the right direction and still pull repair in the wrong one. The new data are a reminder that pathway activation and tissue healing are not the same thing.
9mMOTS-C sits at the intersection of mitochondrial signaling, metabolism, and longevity. July 2026 put it back in the spotlight for a reason.
8mMOTS-c is not just a mitochondrial story. In human cells, the same signal that turns on metabolism may also dampen repair, which makes context matter.
8mNew MOTS-C data points to something more specific than a generic metabolism story: better muscle mitochondrial efficiency. Here's what that means in practice.
8mMOTS-c is being studied beyond energy and metabolism. New research points toward tissue-stress biology, lysosomal stability, and cell survival under ischemic pressure.
8mMOTS-c is one of the most interesting mitochondrial peptides in 2026 because the question is finally shifting from mechanism to human outcomes.
9mDiscovered inside mitochondrial DNA itself, MOTS-c is one of the most fascinating longevity peptides in modern science. It governs how your cells produce energy, fight fat accumulation, and age.
9mMOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. It has strong mouse data, one recruiting placebo-controlled human trial and no FDA approval. In October 2026 HHS added it to an interim compounding policy.
10mRetatrutide is not just a stronger tirzepatide. It's a fundamentally different molecule with three receptor targets instead of two. Here's how each mechanism contributes to rapid fat loss, metabolic optimization, and muscle preservation.
12mGLP-1 agonists have revolutionized metabolic health. Learn how these peptides work, their effects on metabolism, and how to use them strategically for body composition goals.
8mDiscover how AOD-9604 targets fat metabolism specifically, offering a focused approach to body composition.
Also available at /blog for legacy links.